Follow the AILERON THERAPEUTICS INC stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 6 March 2024 (Levée d'options). Among the most active insiders: WINDSOR JAMES BRIAN. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
AILERON THERAPEUTICS INC es una empresa biofarmacéutica centrada en el desarrollo de terapias basadas en péptidos para enfermedades graves. Cotiza en NASDAQ bajo el ticker AILN.